Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Castlight Health

DB:109
Snowflake Description

Adequate balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
109
DB
$108M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Castlight Health, Inc. provides a software-as-a-service platform used for health benefits navigation for employees in the United States. The last earnings update was 32 days ago. More info.


Add to Portfolio Compare Print
  • Castlight Health has significant price volatility in the past 3 months.
109 Share Price and Events
7 Day Returns
-3.7%
DB:109
9.5%
DE Healthcare Services
9.9%
DE Market
1 Year Returns
-80.2%
DB:109
0.2%
DE Healthcare Services
-17.5%
DE Market
109 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Castlight Health (109) -3.7% -23.4% -42.5% -80.2% -80.5% -90.7%
DE Healthcare Services 9.5% -6.5% -16.6% 0.2% 27.1% 88.9%
DE Market 9.9% -16.6% -24.8% -17.5% -24.5% -28.1%
1 Year Return vs Industry and Market
  • 109 underperformed the Healthcare Services industry which returned 0.2% over the past year.
  • 109 underperformed the Market in Germany which returned -17.5% over the past year.
Price Volatility
109
Industry
5yr Volatility vs Market

Value

 Is Castlight Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Castlight Health to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Castlight Health.

DB:109 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 5.5%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:109
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Healthcare Services Unlevered Beta Simply Wall St/ S&P Global 0.97
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.971 (1 + (1- 21%) (19.45%))
1.081
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.08
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (1.081 * 5.44%)
5.49%

Discounted Cash Flow Calculation for DB:109 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Castlight Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

DB:109 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 5.49%)
2020 -19.30 Analyst x2 -18.30
2021 -8.55 Analyst x2 -7.68
2022 -5.70 Analyst x1 -4.86
2023 -6.03 Est @ 5.72% -4.87
2024 16.34 Analyst x2 12.51
2025 16.98 Est @ 3.89% 12.32
2026 17.42 Est @ 2.61% 11.99
2027 17.72 Est @ 1.71% 11.56
2028 17.91 Est @ 1.08% 11.07
2029 18.03 Est @ 0.64% 10.56
Present value of next 10 years cash flows $34.00
DB:109 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $18.03 × (1 + -0.39%) ÷ (5.49% – -0.39%)
$305.37
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $305.37 ÷ (1 + 5.49%)10
$178.95
DB:109 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $34.00 + $178.95
$212.95
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $212.95 / 149.26
$1.43
DB:109 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:109 represents 0.90582x of NYSE:CSLT
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.90582x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 1.43 x 0.90582
€1.29
Value per share (EUR) From above. €1.29
Current discount Discount to share price of €0.66
= -1 x (€0.66 - €1.29) / €1.29
49.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Castlight Health is available for.
Intrinsic value
49%
Share price is €0.66 vs Future cash flow value of €1.29
Current Discount Checks
For Castlight Health to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Castlight Health's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Castlight Health's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Castlight Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Castlight Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:109 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-0.28
NYSE:CSLT Share Price ** NYSE (2020-03-31) in USD $0.72
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.39x
Germany Market PE Ratio Median Figure of 399 Publicly-Listed Companies 16.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Castlight Health.

DB:109 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:CSLT Share Price ÷ EPS (both in USD)

= 0.72 ÷ -0.28

-2.62x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Castlight Health is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • Castlight Health is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Castlight Health's expected growth come at a high price?
Raw Data
DB:109 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.62x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
12.6%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.3x
Germany Market PEG Ratio Median Figure of 255 Publicly-Listed Companies 1.18x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Castlight Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Castlight Health's assets?
Raw Data
DB:109 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $1.17
NYSE:CSLT Share Price * NYSE (2020-03-31) in USD $0.72
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.94x
Germany Market PB Ratio Median Figure of 571 Publicly-Listed Companies 1.43x
DB:109 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:CSLT Share Price ÷ Book Value per Share (both in USD)

= 0.72 ÷ 1.17

0.62x

* Primary Listing of Castlight Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Castlight Health is good value based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess Castlight Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Castlight Health has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Castlight Health expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Castlight Health expected to grow at an attractive rate?
  • Unable to compare Castlight Health's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Castlight Health's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • Castlight Health's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:109 Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:109 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 12.6%
DB:109 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 5.8%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.3%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.4%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:109 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:109 Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-12-31 185 31 -20 2
2023-12-31 167 22 -28 2
2022-12-31 157 15 -32 3
2021-12-31 144 4 -31 5
2020-12-31 133 -13 -42 6
2020-03-31
DB:109 Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 143 -17 -40
2019-09-30 149 -14 -32
2019-06-30 154 -12 -30
2019-03-31 155 -12 -36
2018-12-31 156 -19 -40
2018-09-30 151 -26 -43
2018-06-30 146 -29 -54
2018-03-31 141 -32 -52
2017-12-31 132 -23 -52
2017-09-30 125 -25 -54
2017-06-30 116 -26 -47
2017-03-31 107 -34 -52

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Castlight Health is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Castlight Health's revenue is expected to grow by 5.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:109 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Castlight Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:109 Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-12-31 -0.12 -0.12 -0.12 1.00
2023-12-31 -0.17 -0.17 -0.17 1.00
2022-12-31 -0.20 -0.20 -0.20 1.00
2021-12-31 -0.20 -0.20 -0.20 2.00
2020-12-31 -0.28 -0.27 -0.28 2.00
2020-03-31
DB:109 Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -0.28
2019-09-30 -0.23
2019-06-30 -0.21
2019-03-31 -0.26
2018-12-31 -0.29
2018-09-30 -0.31
2018-06-30 -0.40
2018-03-31 -0.39
2017-12-31 -0.41
2017-09-30 -0.46
2017-06-30 -0.43
2017-03-31 -0.50

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Castlight Health will efficiently use shareholders’ funds in the future (Return on Equity greater than 20%) as it is not expected to be profitable.
X
Future performance checks
We assess Castlight Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Castlight Health has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Castlight Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Castlight Health's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Castlight Health does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Castlight Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Castlight Health's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Castlight Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Castlight Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:109 Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 143.31 -40.00 66.58 58.99
2019-09-30 148.96 -32.30 66.42 60.21
2019-06-30 153.54 -30.22 66.74 60.69
2019-03-31 155.42 -35.80 70.53 60.81
2018-12-31 156.40 -39.71 74.75 60.46
2018-09-30 151.50 -42.82 74.78 59.18
2018-06-30 145.95 -53.55 82.60 58.22
2018-03-31 140.80 -51.97 83.76 58.80
2017-12-31 132.02 -51.90 86.16 54.50
2017-09-30 124.72 -53.84 89.28 49.92
2017-06-30 115.73 -47.25 83.35 46.68
2017-03-31 106.69 -51.57 83.98 41.45
2016-12-31 98.71 -58.69 82.60 40.46
2016-09-30 93.12 -68.51 84.44 38.84
2016-06-30 87.16 -77.11 89.00 36.14
2016-03-31 82.08 -81.63 91.69 33.57
2015-12-31 75.32 -79.92 91.69 30.08
2015-09-30 68.49 -80.55 87.82 28.14
2015-06-30 61.16 -80.74 84.48 25.90
2015-03-31 53.18 -81.30 79.79 23.98
2014-12-31 45.61 -85.94 78.44 22.92
2014-09-30 36.25 -86.23 74.94 21.19
2014-06-30 27.65 -82.63 66.51 19.70
2014-03-31 19.44 -75.03 56.13 17.84
2013-12-31 12.97 -62.18 42.79 15.22
2013-09-30 9.17 -53.40 34.77 13.53

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Castlight Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Castlight Health has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Castlight Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Castlight Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Castlight Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Castlight Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Castlight Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Castlight Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Castlight Health's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Castlight Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 29.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Castlight Health Company Filings, last reported 3 months ago.

DB:109 Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 172.87 3.25 59.43
2019-09-30 180.30 3.72 56.02
2019-06-30 186.51 4.18 63.93
2019-03-31 189.83 4.65 66.34
2018-12-31 194.67 3.25 77.33
2018-09-30 192.66 5.58 68.41
2018-06-30 195.23 5.58 74.48
2018-03-31 202.24 5.58 74.61
2017-12-31 211.56 4.96 93.34
2017-09-30 177.28 5.62 87.06
2017-06-30 188.81 5.58 96.02
2017-03-31 93.34 0.00 103.21
2016-12-31 101.96 0.00 114.60
2016-09-30 105.09 0.00 116.43
2016-06-30 110.22 0.00 125.69
2016-03-31 103.86 0.00 120.50
2015-12-31 118.35 0.00 120.42
2015-09-30 131.85 0.00 147.20
2015-06-30 146.40 0.00 164.44
2015-03-31 162.13 0.00 185.77
2014-12-31 176.19 0.00 192.48
2014-09-30 189.97 0.00 182.16
2014-06-30 205.55 0.00 159.83
2014-03-31 224.25 0.00 219.38
2013-12-31 56.07 0.00 67.17
2013-09-30 74.59 0.00 76.05
  • Castlight Health's level of debt (1.9%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Castlight Health's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Castlight Health has sufficient cash runway for more than 3 years based on current free cash flow.
  • Unable to confirm if Castlight Health has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess Castlight Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Castlight Health has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Castlight Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Castlight Health dividends.
If you bought €2,000 of Castlight Health shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Castlight Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Castlight Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:109 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.8%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:109 Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2020-03-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Castlight Health has not reported any payouts.
  • Unable to verify if Castlight Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Castlight Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Castlight Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Castlight Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Castlight Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Castlight Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Castlight Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Maeve O'Meara
COMPENSATION $2,997,799
TENURE AS CEO 0.7 years
CEO Bio

Ms. Maeve O'Meara is the Chief Executive Officer and Director of Castlight Health, Inc. since July 2019. She served as an Executive Vice President of Product and Customer Experience at Castlight Health, Inc., since June 11, 2018 until July 2019. Ms. O’Meara joined Castlight Health in 2010. She served as Chief Product Officer of Castlight Health, Inc. since 2018 until June 11, 2018 and served as its Senior Vice President of Products until 2018. She served as an Associate at Highland Capital Partners. She focused on healthcare investments. Prior to joining Highland, she served as a Senior Associate Consultant at Bain & Company, where she worked primarily in the healthcare and consumer products practice areas. While at Bain, she advised clients on acquisitions and developed growth and go-to-market strategies across the U.S. and Europe. Most recently, Ms. O’Meara led the design and delivery of Anthem Engage, Castlight’s first combined wellbeing and care guidance offering. She has also worked for a private hospital and the National Health System in Costa Rica for six months. She spent time at Generation Health, where she led original product design and development. Ms. O'Meara holds an MBA from Stanford Graduate School of Business and a BA in Economics from the University of Virginia.

CEO Compensation
  • Insufficient data for Maeve to compare compensation growth.
  • Maeve's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Castlight Health management team in years:

0.7
Average Tenure
46
Average Age
  • The average tenure for the Castlight Health management team is less than 2 years, this suggests a new team.
Management Team

Bryan Roberts

TITLE
Chairman of the Board & Co-Founder
COMPENSATION
$212K
AGE
52
TENURE
12.2 yrs

Maeve O'Meara

TITLE
CEO & Director
COMPENSATION
$3M
TENURE
0.7 yrs

Will Bondurant

TITLE
Senior VP & CFO
AGE
30
TENURE
0.3 yrs

Helen Kotchoubey

TITLE
Executive VP & COO
AGE
46
TENURE
0.4 yrs

M P Chan

TITLE
Chief Accounting Officer
AGE
43
TENURE
2.6 yrs

Gary Fuges

TITLE
Head of Investor Relations

Alex Shvartsman

TITLE
Senior VP & General Counsel
TENURE
1.2 yrs

Matt Moran

TITLE
Senior Vice President of Corporate Development
TENURE
0.4 yrs

John McCracken

TITLE
Chief Revenue Officer
COMPENSATION
$3M
AGE
52
TENURE
3.7 yrs

Keith Reynolds

TITLE
Chief Commercial Officer
TENURE
0.2 yrs
Board of Directors Tenure

Average tenure and age of the Castlight Health board of directors in years:

3.6
Average Tenure
51
Average Age
  • The tenure for the Castlight Health board of directors is about average.
Board of Directors

Bryan Roberts

TITLE
Chairman of the Board & Co-Founder
COMPENSATION
$212K
AGE
52
TENURE
2.4 yrs

Maeve O'Meara

TITLE
CEO & Director
COMPENSATION
$3M
TENURE
0.7 yrs

David Ebersman

TITLE
Independent Director
COMPENSATION
$180K
AGE
50
TENURE
8.7 yrs

Ed Park

TITLE
Independent Director
COMPENSATION
$197K
AGE
44
TENURE
5.8 yrs

David Singer

TITLE
Independent Director
COMPENSATION
$182K
AGE
56
TENURE
9.7 yrs

Mike Eberhard

TITLE
Independent Director
COMPENSATION
$185K
AGE
53
TENURE
3.7 yrs

Kenny Van Zant

TITLE
Independent Director
COMPENSATION
$175K
AGE
49
TENURE
3.6 yrs

Seth Cohen

TITLE
Director
COMPENSATION
$382K
AGE
38
TENURE
2.2 yrs

Judy Verhave

TITLE
Independent Director
COMPENSATION
$232K
AGE
62
TENURE
1.7 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Castlight Health individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
30. Mar 20 Sell Raging Capital Management, LLC Company 04. Mar 20 05. Mar 20 -225,652 €0.90 €-202,781
12. Mar 20 Buy Will Bondurant Individual 10. Mar 20 10. Mar 20 40,000 €0.76 €30,584
12. Mar 20 Buy Maeve O'Meara Individual 12. Mar 20 12. Mar 20 75,000 €0.74 €55,747
04. Mar 20 Buy Kenny Van Zant Individual 03. Mar 20 04. Mar 20 250,000 €0.93 €232,053
X
Management checks
We assess Castlight Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Castlight Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Castlight Health, Inc. provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services. It serves customers in a range of industries, including education, manufacturing, retail, technology, and government. The company was formerly known as Ventana Health Services and changed its name to Castlight Health, Inc. in April 2010. Castlight Health, Inc. was founded in 2008 and is headquartered in San Francisco, California.

Details
Name: Castlight Health, Inc.
109
Exchange: DB
Founded: 2008
$98,216,167
149,259,929
Website: http://www.castlighthealth.com
Address: Castlight Health, Inc.
150 Spear Street,
Suite 400,
San Francisco,
California, 94105,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE CSLT Class B Common Stock New York Stock Exchange US USD 14. Mar 2014
DB 109 Class B Common Stock Deutsche Boerse AG DE EUR 14. Mar 2014
BRSE 109 Class B Common Stock Berne Stock Exchange CH CHF 14. Mar 2014
Number of employees
Current staff
Staff numbers
463
Castlight Health employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 23:06
End of day share price update: 2020/03/31 00:00
Last estimates confirmation: 2020/03/05
Last earnings filing: 2020/02/28
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.